Novel Albumin–Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Albumin–Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Authors
Keywords
Hepatocellular carcinoma, Trancatheter arterial chemoembolization, Albumin–bilirubin grade
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 63, Issue 4, Pages 1062-1071
Publisher
Springer Nature
Online
2018-02-13
DOI
10.1007/s10620-018-4934-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
- (2016) Riccardo Lencioni et al. HEPATOLOGY
- The ALBI Grade Provides Objective Hepatic Reserve Phenotyping across Each BCLC Stage of Hepatocellular Carcinoma
- (2016) D.J. Pinato et al. JOURNAL OF HEPATOLOGY
- The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
- (2016) Kwang Min Kim et al. LIVER INTERNATIONAL
- A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma
- (2016) Julien Edeline et al. LIVER INTERNATIONAL
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
- (2015) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
- (2015) Xavier Adhoute et al. JOURNAL OF HEPATOLOGY
- Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model
- (2015) Beom Kyung Kim et al. LIVER INTERNATIONAL
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
- (2014) Dong Hyun Sinn et al. PLoS One
- Small Single-Nodule Hepatocellular Carcinoma: Comparison of Transarterial Chemoembolization, Radiofrequency Ablation, and Hepatic Resection by Using Inverse Probability Weighting
- (2014) Hyo-Joon Yang et al. RADIOLOGY
- The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
- (2013) Wolfgang Sieghart et al. HEPATOLOGY
- Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (
- (2011) Rita Golfieri et al. HEPATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival
- (2011) Goh Eun Chung et al. RADIOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started